These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 8377305)

  • 1. [Radionuclide therapy of thyroid disease--radioactive iodine therapy].
    Kusakabe K; Maki M
    Kaku Igaku; 1993 Jul; 30(7):813-9. PubMed ID: 8377305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma.
    Schlumberger M; Challeton C; De Vathaire F; Travagli JP; Gardet P; Lumbroso JD; Francese C; Fontaine F; Ricard M; Parmentier C
    J Nucl Med; 1996 Apr; 37(4):598-605. PubMed ID: 8691248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of radioiodine therapy in 47 patients with distant metastases of differentiated thyroid carcinoma].
    Miyamoto S; Kasagi K; Endo K; Iida Y; Hidaka A; Hatabu H; Konishi J
    Nihon Igaku Hoshasen Gakkai Zasshi; 1991 Jul; 51(7):810-21. PubMed ID: 1891347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic follicular carcinoma of the thyroid: reappearance of radioiodine uptake.
    Oyen WJ; Mudde AH; van den Broek WJ; Corstens FH
    J Nucl Med; 1995 Apr; 36(4):613-5. PubMed ID: 7699452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of stunning of lung and bone metastases of papillary thyroid cancer after a therapeutic dose (3.7 GBq) of 131I and review of the literature: implications for sequential treatments.
    Leger AF; Pellan M; Dagousset F; Chevalier A; Keller I; Clerc J
    Br J Radiol; 2005 May; 78(929):428-32. PubMed ID: 15845937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [131I-therapy of differentiated thyroid carcinoma with distant metastases--relation between absorbed dose by quantitative SPECT and outcome of the patients in thyroid carcinoma].
    Aritake S; Kusakabe K; Kanaya S; Kanaya K; Nakano K; Ota T; Maki M; Shigeta A
    Kaku Igaku; 1993 Jan; 30(1):51-60. PubMed ID: 8455341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of radioiodine therapy in patients with pulmonary metastases of differentiated thyroid cancer].
    Ono Y; Yamamoto Y; Nishiyama Y; Nakano S; Takahashi K; Kawasaki Y; Satoh K; Ohkawa M; Tanabe M
    Kaku Igaku; 2000 Nov; 37(6):661-70. PubMed ID: 11193452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiated thyroid cancer following radioiodide 131I therapy of hyperthyroidism--a case report.
    Nĕmec J; Soumar J; Zeman V; Nahodil V; Zamrazil V; Smejkal V
    Oncology; 1978; 35(6):277-80. PubMed ID: 745812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow dosimetry and safety of high 131I activities given after recombinant human thyroid-stimulating hormone to treat metastatic differentiated thyroid cancer.
    de Keizer B; Hoekstra A; Konijnenberg MW; de Vos F; Lambert B; van Rijk PP; Lips CJ; de Klerk JM
    J Nucl Med; 2004 Sep; 45(9):1549-54. PubMed ID: 15347723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioiodine treatment of metastatic thyroid carcinoma: the Royal Marsden Hospital experience.
    Brown AP; Greening WP; McCready VR; Shaw HJ; Harmer CL
    Br J Radiol; 1984 Apr; 57(676):323-7. PubMed ID: 6704664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lungs absorbed dose in radioiodine therapy of differentiated thyroid carcinoma with diffuse pulmonary metastases].
    Liu B; Zeng Y; Wang J; Zhao Z; Mu D; Kuang A
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Aug; 27(4):851-4. PubMed ID: 20842858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical management and outcomes in patients with hyperfunctioning distant metastases from differentiated thyroid cancer after total thyroidectomy and radioactive iodine therapy.
    Qiu ZL; Shen CT; Luo QY
    Thyroid; 2015 Feb; 25(2):229-37. PubMed ID: 25331724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent progress in radionuclide therapy].
    Kasagi K; Iwata M; Misaki T; Konishi J; Sakahara H
    Nihon Igaku Hoshasen Gakkai Zasshi; 2000 Nov; 60(13):729-37. PubMed ID: 11140321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study.
    Andrade VA; Gross JL; Maia AL
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3488-93. PubMed ID: 11502768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetry-guided radioactive iodine treatment in patients with metastatic differentiated thyroid cancer: largest safe dose using a risk-adapted approach.
    Dorn R; Kopp J; Vogt H; Heidenreich P; Carroll RG; Gulec SA
    J Nucl Med; 2003 Mar; 44(3):451-6. PubMed ID: 12621014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the outcome between the calculated dosimetry and the estimated dosimetry of 131I in the treatment of hyperthyroidism.
    Sun JH; Huang HS; Huang MJ; Huang BY; Lin JD; Hsu BR; Chiou SC; Lo SK
    Changgeng Yi Xue Za Zhi; 1995 Dec; 18(4):322-8. PubMed ID: 8851980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the therapeutic dose and diagnostic dose of 131I in the detection of metastatic foci of differentiated thyroid cancer.
    Tung CC; Chang TC; Su CT; Chen FW; Chang CC
    Taiwan Yi Xue Hui Za Zhi; 1988 Nov; 87(11):1081-5. PubMed ID: 3235967
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experience with a high-dose therapy concept in metastatic differentiated thyroid cancer].
    Grünwald F; Ruhlmann J; Ammari B; Knopp R; Hotze A; Biersack HJ
    Nuklearmedizin; 1988 Dec; 27(6):266-71. PubMed ID: 3217257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractionated radioiodine therapy for hyperthyroidism caused by widespread metastatic follicular thyroid carcinoma.
    Nishihara E; Amino N; Miyauchi A
    Thyroid; 2010 May; 20(5):569-70. PubMed ID: 20384491
    [No Abstract]   [Full Text] [Related]  

  • 20. 123I isotope as a diagnostic agent in the follow-up of patients with differentiated thyroid cancer: comparison with post 131I therapy whole body scanning.
    Alzahrani AS; Bakheet S; Al Mandil M; Al-Hajjaj A; Almahfouz A; Al Haj A
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5294-300. PubMed ID: 11701695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.